Mexican lawmakers will hash out the details of a marijuana regulation bill during the upcoming summer recess, with the goal of passing the legislation ahead of an October deadline, a key committee leader said.
Mexico plans to legalize cannabis by October 2019 Read more
Research from Johns Hopkins University finds that MDMA seems to re-open a window of opportunity for social bonding and rewiring trauma-related faulty connections in the brain.
The newly-approved drug, sold under the brand name Zulresso, was shown to relieve depressive symptoms within hours of being administered in three different clinical trials — and it continued to show success throughout their 30-day followups.
U.S. FDA approves first ever treatment for postpartum depression Read more
Global health experts at the United Nations are recommending that marijuana and its key components be formally rescheduled under international drug treaties. WHO is also moving to make clear that CBD-focused preparations containing no more than 0.2 percent THC are “not under international control” at all.
The hope is that the AI will allow school officials to identify the bullying cases that are likely to escalate in seriousness so that they can intervene and diffuse the situation before it’s too late.
Japanese city of Otsu is using AI to prevent youth suicides Read more
Brain changes associated with leaky capillaries suggest new, potential drug targets as well as a way to diagnose the disease sooner.
USC researchers find new culprit and potential treatment target for Alzheimer’s Read more
There is no one reason for the global decline, but it is particularly notable among young women in China and India, middle-aged men in Russia, and the elderly.
Global suicide rate has declined by 29% since 2000, saving 2.8 millions lives Read more
A small clinical trial published last week in the Journal of Psychopharmacology found that therapeutic doses of MDMA, in concert with psychotherapy, reduced the severity of most participants’ PTSD symptoms.
MDMA therapy eliminated PTSD symptoms in 76% of patients Read more
The US Food and Drug Administration has just granted a “Breakthrough Therapy” designation to a treatment that uses psychedelic mushrooms as a therapy for treatment-resistant depression.
Robotics startup LuxAI has created QTrobot, a bot designed to help children with autism learn valuable social skills.
New therapy bot helps children with autism perfect their social skills Read more
